SPI1 and cancer: It was found that upon the suppression of LINC01004 or SPI1 and the subsequent SIGLEC9 inhibition, the DNA synthesis ability, and the migration and invasion activities of cancer cells were significantly suppressed (Fig. 6d–f), along with increased necrosis rate of cells (Fig. 6g).